Monitoring of noncommunicable diseases

Abstract

Noncommunicable diseases (NCDs) represent a major fraction of the global health burden in terms of morbidity and mortality, and its prevalence is on the rise across the world. As more and more people are living with various NCD, primary and secondary prevention becomes an important tool to contain this impending epidemic. The spectrum of major NCD includes cardiovascular disorders (CVD), diabetes mellitus (DM), chronic obstructive pulmonary disorder (COPD), and cancer, with CVD contributing to the majority of deaths attributed to NCD. Control of hypertension is important intervention which can significantly decrease the risk of CVD, which can be achieved by three-pronged approaches such as encompassing dietary, physical exercise, and pharmacological interventions. Monitoring is an integral part of this approach, wherein recording of blood pressure and various investigations are required to be done at variable intervals. DM is an important NCD where primary and secondary preventions are of paramount importance. Similarly, other NCDs such as COPD and cancer also require various monitoring protocols. In this article, we review the current concepts in monitoring and prevention of major NCDs along with the recommendations from the scientific societies.

Cardiovascular disorders - diabetes - monitoring - noncommunicable diseases - screening

• References

• 1 Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H. et al. Acomparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2224-2260
• 2 Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscaizo J. Harrison's principles of internal medicine. 19th ed:. New York: McGraw Hill Education; 2015. p. 298, 1612-1624
• 3 Huber-Geismann F. Primary prevention in mild hypertension. Praxis (Bern 1994) 2013; 102: 55
• 4 Sheridan S, Pignone M. Primary prevention: Hypertension. Clin Evid 2005; 14: 151-159
• 5 Ravenni R, Jabre JF, Casiglia E, Mazza A. Primary stroke prevention and hypertension treatment: Which is the first-line strategy?. Neurol Int 2011; 3: e12
• 6 Sheridan S. Primary prevention of CVD: Treating hypertension. BMJ Clin Evid 2007 2007; 0214
• 7 Klonizakis M, Alkhatib A, Middleton G, Smith MF. Mediterranean diet- and exercise-induced improvement in age-dependent vascular activity. Clin Sci (Lond) 2013; 124: 579-587
• 8 Kwan MW, Wong MC, Wang HH, Liu KQ, Lee CL, Yan BP. et al. Compliance with the Dietary Approaches to Stop Hypertension (DASH) diet: A systematic review. PLoS One 2013; 8: e78412
• 9 Joel Handler MJ. Essential Hypertension. UK: The BMJ Group; 2016. Available from: http://www.bestpractice.bmj.com/best.practice/monograph/26/follow.up/recommendations.html [Last updated on 2016 Feb 03; Last cited on 2016 Jun 29].
• 10 American Cancer Society Guidelines for the Early Detection of Cancer. American Cancer Society, Inc, No 207000 Rev 9/15. Available from: http://www.cancer.org/acs/groups/content/@editorial/documents/document/acspc.046343.pdf [Last accessed on 2016 Jul 22].
• 11 Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T. et al. Diagnosis and management of stable chronic obstructive pulmonary disease: A clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 2011; 155: 179-191
• 12 van den Bemt L, Schermer T, Smeele I, Bischoff E, Jacobs A, Grol R. et al. Monitoring of patients with COPD: A review of current guidelines' recommendations. Respir Med 2008; 102: 633-641
• 13 Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347-365
• 14 Wagena EJ, van der Meer RM, Ostelo RJ, Jacobs JE, van Schayck CP. The efficacy of smoking cessation strategies in people with chronic obstructive pulmonary disease: Results from a systematic review. Respir Med 2004; 98: 805-815
• 15 International Diabetes Federation. IDF Diabetes Atlas. 6th ed.. Brussels, Belgium: International Diabetes Federation; 2013
• 16 2016 American Diabetes Association (ADA) Diabetes guidelines summary and recommendation from ADEI. http://www.ndei.org/ADA-diabetes-management-guidelines-diagnosis-A1C-testing.aspx.html [Last accesed on 2016 Jul 04].
• 17 International Diabetes Federation, 2012. Global Guidelines for Type 2 Diabetes. Available from: https://www.idf.org/sites/default/files/IDF%20T2DM%20Guideline.pdf [Last accessed on 2016 Jul 20].
• 18 Kurien M, Mollazadegan K, Sanders DS, Ludvigsson JF. Celiac disease increases risk of thyroid disease in patients with type 1 diabetes: A Nationwide cohort study. Diabetes Care 2016; 39: 371-375